Drug metabolism by tumours: its nature, relevance and therapeutic implications.

@article{Michael2007DrugMB,
  title={Drug metabolism by tumours: its nature, relevance and therapeutic implications.},
  author={Michael Michael and Margaret M. Doherty},
  journal={Expert opinion on drug metabolism & toxicology},
  year={2007},
  volume={3 6},
  pages={783-803}
}
Drug-metabolising enzymes (DMEs) are present in tumours and are capable of biotransforming a variety of antineoplastics. Tumoural drug metabolism is both a potential mechanism of resistance and a means of achieving optimal therapy. This review addresses the classes of DMEs, their cytotoxic substrates and distribution in specific malignancies. The limitations of preclinical and clinical studies are highlighted. Their role in predicting therapeutic response, the activation of prodrugs and the… CONTINUE READING